Investigating the effects of new tobacco-free nicotine pouches on users and marketing influences.
Novel "Tobacco-Free" Oral Nicotine Pouches: The impact of Product Features and Marketing Influences on Abuse Liability, Perceptions, and Use Behavior in Smokers and Non-Nicotine Users
This study is looking at a new kind of nicotine pouch that doesn't use tobacco leaves, to see how its features and advertising affect how people feel about it and whether it might lead to addiction, especially among young people and current smokers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11056838 on NIH RePORTER |
What this research studies
This research explores a new type of oral nicotine pouch that uses nicotine powder instead of tobacco leaves, focusing on how product features and marketing strategies influence user behavior and perceptions. The study aims to understand the potential for addiction and the impact of advertising, especially on youth and current smokers. By conducting human lab studies and analyzing marketing tactics, the research seeks to provide insights into the risks and benefits of these products for different populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include current smokers considering alternatives to traditional tobacco products and non-nicotine users, particularly youth.
Not a fit: Patients who are not interested in nicotine products or who have no history of tobacco use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help inform regulations that protect public health by understanding the risks associated with nicotine pouch use.
How similar studies have performed: While there is limited research on these specific nicotine pouches, similar studies on tobacco products have shown significant insights into user behavior and addiction potential.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Spindle, Tory Richard — Johns Hopkins University
- Study coordinator: Spindle, Tory Richard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.